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Abstract
Hypertension is a major health concern in the developed world, and its prevalence
increases with advancing age. The impact of hypertension on the function of the
renal and cardiovascular systems is well studied; however, its influence on the
brain regions important for cognition has garnered less attention. We utilized the
Cyp1a1-Ren2 xenobiotic-inducible transgenic rat model to mimic both the age of
onset and rate of induction of hypertension observed in humans. Male, 15-
month-old transgenic rats were fed 0.15% indole-3-carbinol (I3C) chow to slowly
induce renin-dependent hypertension over a 6-week period. Systolic blood pres-
sure significantly increased, eventually reaching 200 mmHg by the end of the
study period. In contrast, transgenic rats fed a control diet without I3C did not
show significant changes in blood pressure (145 mmHg at the end of study).
Hypertension was associated with cardiac, aortic, and renal hypertrophy as well as
increased collagen deposition in the left ventricle and kidney of the I3C-treated
rats. Additionally, rats with hypertension showed reduced savings from prior spa-
tial memory training when tested on the hippocampus-dependent Morris swim
task. Motor and sensory functions were found to be unaffected by induction of
hypertension. Taken together, these data indicate a profound effect of hyperten-
sion not only on the cardiovascular-renal axis but also on brain systems critically
important for learning and memory. Future use of this model and approach may
empower a more accurate investigation of the influence of aging on the systems
responsible for cardiovascular, renal, and neurological health.
Introduction
Hypertension is the leading risk factor for cardiovascular
disease affecting 40% of middle-aged adults 45–64 years
and 70% of adults over the age of 65 in the United States
(Gillespie and Hurvitz 2013). Wilkie and Eisdorfer (1971)
first reported that the degree of hypertension in adults in
their 60s was associated with significant intellectual
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decline over a 10-year period. This general finding has
been replicated and extended most recently in results
from the Women’s Health Initiative Memory Study, in
which it was found that postmenopausal women with
hypertension are at higher risk for cognitive decline (Har-
ing et al. 2013). Other recent studies have also suggested
that hypertension can impact cognitive function and
brain structure even in the absence of stroke (Kilander
et al. 1998; Harrington et al. 2000; Waldstein et al. 2008;
Tsivgoulis et al. 2009) and it has been shown that gray
matter volume as measured via magnetic resonance imag-
ing can be reduced in the elderly with hypertension (Raz
and Rodrigue 2006). The exact relationship between
hypertension and cognitive decline, however, remains to
be discovered.
A number of animal models have been developed to
experimentally explore mechanisms through which
hypertension has its impact on cognition. Among these
include uninephrectomy-induced hypertension (Jabaris
et al. 2015a, b), genetic models such as Dahl salt-sensi-
tive rats in which hypertension can be induced by a
high sodium diet (Hirawa et al. 1999; Terry et al. 2001),
chronic angiotensin II infusion to elevate blood pressure
(Jing et al. 2012; Duchemin et al. 2013), and the sponta-
neously hypertensive rat (Wyss et al. 1992; Kantachu-
vesiri et al. 2001). There have, however, been a number
of limitations to these models that make translation of
the findings from these studies problematic. For exam-
ple, experiments have been performed either in young
hypertensive animal models, or older hypertensive rats
in which blood pressure was elevated early in life. Given
that hypertension tends to develop in middle age, an
ideal model would use middle aged animals and a time
course of hypertension induction that mimics known
disease development more closely. A relatively new
model of inducible renin-dependent hypertension, the
Cyp1a1-Ren2 transgenic rat, allows the possibility of
normal development and titrated induction of hyperten-
sion through the administration of a dietary-based mole-
cule (Meneses et al. 1996). This model is particularly
powerful because it is based on the National Institute
on Aging’s colony of F344 rats which has produced the
largest historical collection of data related to the study
of normative aging in rats.
In this study, we more closely model human hyperten-
sion onset by inducing blood pressure increases in the
middle aged Cyp1a1-Ren2 rat. We investigate cardiac,
renal, and vascular end organ changes elicited by the mid-
dle-aged increase in blood pressure as well as the effects
on spatial memory. We suggest that modeling hyperten-
sion in this approach has implications for the future
investigation of the role of increased blood pressure on
both peripheral and central organ systems.
Methods
Subjects
Fischer 344 rats made transgenic by the insertion of the
mouse Ren2 renin gene fused to the cytochrome P450 1a1
promoter were used in these studies (Cyp1a1-Ren2 (Mitch-
ell et al. 2006)). In this model, the rats are fed aryl hydro-
carbon indole-3-carbinol (I3C) that leads to the expression
of Ren2 in the liver, increasing the circulating levels of
renin and ultimately angiotensin II, resulting in elevated
blood pressure. This dietary supplement can be added to
rat chow in low levels, so that blood pressure is slowly
increased over time. This makes it possible to regulate the
rate and duration of blood pressure increases in rats in a
way that mimics the development of hypertension in
humans. Twenty-five middle-aged (15 months) male
Cyp1a1-Ren2 rats were used in this study, 13 that were
given 0.15% I3C-containing chow, and 12 that received the
same chow without I3C (controls). I3C administration
continued for 32 days. The animals were randomly
assigned to groups. Chow was freely available throughout
the study. Rats were single-housed under a reverse light/
dark cycle. This study was approved by the University of
Arizona Institutional Animal Care and Use Committee and
was conducted in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Ani-
mals. All rats used in this study were bred at Tulane
University School of Medicine, New Orleans, LA.
Blood pressure monitoring
Experimental blood pressure measurements were obtained
from all animals on two occasions during the week prior to
the addition of the I3C compound to the treatment
group’s chow. The device used for monitoring blood pres-
sure was specifically designed for rodent use (CODA moni-
tor and restrainer, noninvasive blood pressure monitoring
system, Serial #SB0573, Kent Scientific). To obtain read-
ings, animals were inserted into a snug plastic tube covered
with a warming pad. Two cuffs (0.5 and 1.5 inches) were
wrapped around the base of the animal’s tail, and stable
readings taken within 5–8 min of tube insertion. Animals
were first adapted to blood pressure monitoring until they
were comfortable with the procedure, which involved plac-
ing rats in the tube for ~15 min. For experimental mea-
surements, three separate readings were taken on any given
day to ensure equipment and animal stability.
Behavioral testing procedures
Spatial learning and memory was assessed using the Mor-
ris swim task, which is a hippocampus-dependent
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cognitive task. Experimenters were blinded to groups, and
testing was randomized such that the hypertensive and
control rats were not grouped when they were tested. The
animals were tested throughout the same day. The
detailed procedure for testing was as in Shen and Barnes
(1996). Briefly, rats were given health checks and handled
in the week before training. Rats were initially placed
onto the hidden platform of the water tank for 30 sec,
before being placed into the pool at pseudorandomly
assigned start locations at the edge of the pool. A total of
six spatial trials were given per day for 4 days (24 trials
total). Following the spatial trials, six trials were given on
each of 2 days (12 trials total) in which the submerged
platform was above the water’s surface (“cued trials”) to
ensure that the animals did not have visual or motor
defects that could influence performance. Since the start
locations and swim velocity vary between animals, a cor-
rected integrated path length (CIPL) is calculated to
ensure comparability of the rats’ performance across
release locations (Gallagher et al. 1993). A two-way
repeated measures ANOVA was used to assess differences
between treatment groups over training trials before the
hypertension treatment began, with alpha levels set at
0.05. The retest procedure was identical to the initial
Morris swim task test, including 24 spatial trials over
4 days (with the platform in the same location) and 12
cued trials over 2 days (in order to determine if the blood
pressure modification impacted motor or visual capacity).
An additional dependent measure for assessing the spatial
learning variable involves how much “savings” occurred
in individual rats between the initial training (before
hypertension was induced) and the “retest” after induc-
tion of hypertension. This was calculated as the difference
in performance for each rat over each trial (“Pre–Post”,
so that it would be a positive value) normalized by divid-
ing by “Pre + Post”. The statistics used for this compar-
ison was a mixed effect model, with treatment as the
random effects variable and test day and group as the
fixed variables.
Experimental Procedure
Rats were shipped from Tulane to Tucson at ages ranging
from 6 to 10 months. They were quarantined for 6–
8 weeks in Tucson. After quarantine was complete, the
rats were handled, weighed, and grossly examined begin-
ning 2 weeks before the start of the experiment. The ini-
tial behavioral assessment, using the Morris swim task,
was given over a 1 week period. Six days after this first
behavior test, diastolic and systolic blood pressure mea-
surements were begun 2 days prior to beginning the I3C
or control diet. Treatment was given for 28 days. The
behavior retest began at day 30 for the final phase of the
experiment (i.e. post-treatment behavior “retest” com-
menced 32 days after treatment onset). Following the
final behavioral test, the animals were euthanized and
organs were collected for analysis.
In additional to the transgenic rats tested, we fed the
I3C and control diet to eight wildtype F344 rats (four rats
were given I3C diet, four rats were given the control
diet). The procedure was identical to that described above
for the transgenic F344 rats. This allowed us to determine
whether the diet impacted behavioral performance with-
out the transgene present.
Heart and kidney weight measurements
Heart and left kidney were rapidly dissected for analysis
of organ weight. The ureter, renal vein, and renal artery
were removed as closely as possible to the renal capsule.
All connective (fascia) and adipose tissue (perirenal fat)
contacting the renal capsule was carefully removed. The
kidney was rinsed with 0.9% NaCl in water and dried
between paper towels. After 2 min of drying the kidney
was weighed. The vena cava, aorta (including aortic arch),
and pulmonary vessels were removed from the heart as
closely as possible to the base of the ventricles. The heart
was immediately immersed in 0.9% NaCl in water to
enable the clearance of as much blood as possible from
the ventricles. The heart was then blotted dry between
paper towels and allowed to dry for 2 min before being
weighed. Body weight of each animal was collected at sac-
rifice and utilized in the analysis of heart and kidney
weights. A Wilcoxon rank-sum (WRS) test was utilized to
identify statistically significant differences (P < 0.05).
Trichrome staining and analysis
Whole mount heart tissue was immersion-fixed in 4%
paraformaldehyde with PBS for 16 h at 4°C, rinsed briefly
in PBS three times to remove residual paraformaldehyde,
and stored in 30% sucrose with PBS at 4°C for 48 h
before being embedded in Tissue-Tek O.C.T Compound
(Sakura Finetek) in a transverse orientation for cryosec-
tioning. The frozen heart tissue was sliced in 6 lm sec-
tions. A minimum of four sections were collected per
animal. Microwave Masson’s Trichrome Stain Kit Proce-
dure (American MasterTech) was used to stain the heart
sections of each animal for collagen. Pictures of each
stained section were taken at 109 using a Zeiss Axio epi-
fluorescent microscope, an Axiocam HRc, and Axiovision
software. The pictures were taken while blinded to the
group, such that there was no information regarding the
hypertensive status of the animal. Sections were thresh-
olded for red (cytoplasm control) or blue (fibrotic colla-
gen deposits) using ImageJ’s (http://rsbweb.nih.gov/ij/)
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Threshold Color plug-in (http://www.dentistry.bham.ac.
uk/landinig/software/software.html) and analyzed with the
histogram tool at Hue = 0 (black). Red was defined at
the hues 205–255, and blue was defined as the hues 150–
200. The data were analyzed for outliers using the
Grubb’s test at a significance level of 0.05, and one outlier
was found and removed from analysis. A Wilcoxon rank-
sum (WRS) test was utilized to identify statistically signif-
icant differences (P < 0.05).
Vascular end organ damage measurements
Paraformaldehyde (4%) fixed transverse sections of tho-
racic aorta (segment obtained between the 2nd and 3rd
intercostal) were dehydrated with graded ethanol solu-
tions, embedded in paraffin and sectioned at 5 lm. Sec-
tions were rehydrated and stained with orcein to identify
elastic fibers. Morphological assessments were made in
409 magnification images using Image J software for
determination of the cross sectional area for the medial
layer of the aorta, lumen diameter, medial wall thickness,
and media-to-lumen ratio. Cellular proliferation was eval-
uated in separate cells based on proliferating cell nuclear
antigen (PCNA) expression, as described previously
(Biwer et al. 2016). Briefly, following rehydration and
antigen retrieval in a 0.01 mol/L Tris-HCl pH 8.6 buffer
in a microwave pressure cooker, sections were blocked
(5% normal goat serum), and incubated overnight at 4°C
with monoclonal mouse anti-PCNA (1:500, Dako), fol-
lowed with anti-mouse secondary (1:200, Dako) and
Streptavidin-HRP (1:400, Dako). Positive staining was
visualized as a brown precipitate after addition of
diaminobenzidine (DAB). Cells positive for PCNA were
counted and normalized to the cross sectional area by a
blinded observer. A Wilcoxon rank-sum (WRS) test was
utilized to identify statistically significant differences
(P < 0.05).
Results
Blood pressure measurements
Animals (n = 25 total) were raised on normal control
chow until they were 15 months old. Prior to hyperten-
sion induction with I3C, baseline indirect blood pressure
measurements were obtained, and no statistically signifi-
cant differences between the treatment and control groups
were noted (151/108 vs. 152/107) (Fig. 1). Indirect sys-
tolic and diastolic blood pressures increased significantly,
however, (with significant differences noted for systolic
and diastolic after 14 and 28 days respectively) over the
course of the 28-day induction period in I3C exposed
rats. At day 28, systolic blood pressure in the I3C treated
animals (n = 13) had reached 195 mmHg (Con:
145 mmHg) on average and diastolic reached an average
of 150 mmHg (Con: 92 mmHg) (Fig. 3). We did not
record heart rate; however, others have measured heart
rate in this same animal model during I3C induction of
hypertension and noted no significant differences (Heij-
nen et al. 2014).
A B
Figure 1. I3C treatment significantly increases blood pressure. I3C treatment significantly increases both (A) systolic and (B) diastolic blood
pressure. Indirect blood pressures were measured using the tail-cuff method approximately once each week. I3C-treated animals (n = 13)
demonstrated a time dependent increase in blood pressure throughout the experimental period. Small filled circles are the measured values for
individual animals in each group (dark gray: I3C treated, light gray: Control, n = 12). Diamonds are the group means and the error bars are the
standard deviation of the means. Linear model fit lines are included. These results demonstrate that the I3C treatment was sufficient to
increase blood pressure in the Cyp1a1-Ren2 animals. Two-way repeated measures ANOVA was performed and the post hoc P-value for
Experimental Day is indicated at the top of the plot (*P < 0.05, **P < 0.01, ***P < 0.0001, N.S. = not significant, P > 0.05).
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Behavioral characterization
Learning and memory performance was tested using the
Morris swim task, both before (“PRE”) and after
(“POST”) treatment with I3C-chow. The performance of
the control and hypertensive rats before treatment is
shown in Figure 2A, which illustrates that there were no
statistically significant differences between groups at the
beginning of the experiment (F23,69 = 0.09, P = >0.05).
After treatment, there were still no significant difference
between the treated and control rats (Fig. 2B,
F23,69 = 0.20, P = >0.05). Because there was a trend in
the pretreatment I3C group to perform better on the
spatial memory task than the randomly assigned con-
trols, we calculated a “cognitive savings” score for each
individual animal for the spatial condition. This score
allows a determination to be made, within a given rat,
of how much the first 24 training trials impacted perfor-
mance on the second set of 24 trials. This number was
obtained by first calculating the CIPL value difference
between the pretreatment and post treatment watermaze
data for each individual rat on each trial. The data were
then normalized for each individual rat across all 4 days,
by the following formula: (pre-post/pre + post). These
values were then averaged for each animal in each group
(control or hypertension) to obtain a savings score for
each day and each treatment group. The CIPL score
decreased for both groups during the “post” testing ses-
sions. The significant effect of group in the mixed model
shows that there were larger differences in CIPL values
between the initial learning and relearning trials in the
control group, compared to the treated animals. Our
hypothesis was that induction of hypertension would
impair the relearning process, thus resulting in lower
“savings” scores in the treated animals. To test whether
treatment affected cognitive savings, a mixed effect
model was employed with animal ID as a random
effects variable and both test day and group (treatment
vs. control group) as fixed effects variables. Treatment
significantly affected savings (v2(1) = 4.11, P = 0.04),
with the hypertension group not benefiting as much
from initial training as did the controls (Fig. 2C “Cogni-
tive Savings”), with treated animals experiencing lower
savings (0.17  0.079) than controls. The 0.17 value is
the average difference between controls and treated ani-
mals across “days,” indicating that savings is greater in
control animals compared to treated animals. The stan-
dard error value (0.079) is the standard deviation of dif-
ferences between controls and treated across “days.” The
reduced savings in the I3C-treated rats could be
explained by faster forgetting of the first set training tri-
als, poorer relearning of the second set of training trials,
or a combination of these factors.
On the other hand, for the cued version of the swim
task, there were no differences, nor trends, between con-
trol or treatment groups in either the PRE or POST
phases (F23,23 = 0.56, P = >0.05; F23,23 = 2.7, P = >0.05,
Fig. 3. This indicates that sensory or motor components
that contribute to task performance cannot account for
the cognitive changes observed in spatial behavior.
In addition to administering the I3C diet to the trans-
geneic F344 rats, we tested the potential impact of the I3C
diet on wildtype F344 rats. We gave four wild type rats the
I3C diet and four wild type rats the global 18% protein diet
for 4 weeks. Systolic and diastolic BP and body weights
A
C
B
Figure 2. Hypertension reduced spatial memory performance on
the Morris water maze. Spatial memory as assessed by Morris
water maze performance was measured before (PRE) and after
(POST) long-term treatment with I3C (n = 13) or Control (n = 12)
chow (dark gray: I3C treated, light gray: Control). Animals were
randomly assigned to treatment groups; however, we noted a
trend in the control chow-assigned animals to perform worse
during the PRE phase. Thus we calculated a Cognitive Savings score
for each individual animal (the difference in performance between
the PRE and POST tasks). We used a mixed effect model with
animal ID as a random effects variable and both test day and group
(treatment vs. control group) as fixed effects variables. Treatment
affected the Cognitive Savings score (v2(1) = 4.11, P = 0.04), with
treated animals experiencing less savings 0.17  0.079 (SEM) than
controls. These results demonstrate that the I3C treatment impaired
spatial reference memory performance in the Cyp1a1-Ren2
animals.
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were measured during the 28 days of treatment, as well as
during the following week of final behavior retest. A two-
way ANOVA showed no significant difference between the
control and I3C rats in body weight – F (1,6), P = 0.92, in
spatial behavior – F (1,31) = 0.26, P = 0.61, or in systolic
BP – F (1,6) = 2.433, P = 0.17, or diastolic BP – F
(1,6) = 5.86, P = 0.052.
Pathological characterization
At sacrifice cardiac and renal measures of end organ
damage were assessed. Heart weight (W = 169,
P = 0.0002), kidney weight (W = 147, P = 0.007), heart
weight to body weight ratio (HW:BW, W = 180.5,
P = 1.6E-05), kidney weight to body weight ratio (KW:
BW, W = 178, P = 2.7E-05), cardiac fibrosis
(W = 144.5, P = 0.01), and renal fibrosis (W = 141.5,
P = 0.02) were all significantly different versus the con-
trol chow animals (Wilcoxon ranked sum test P-values,
Fig. 4). Slightly larger effect sizes for all end organ dam-
age measurements were noted for the heart. Figure 5
illustrates representative examples of Masson’s trichrome
staining of cardiac and renal tissue demonstrating
enhanced collagen deposition in I3C treated rats.
Figure 6 demonstrates the end organ damage measure-
ments performed on the thoracic aorta. The I3C-treated
rats had marked histological and proliferative changes in
their aortas compared to control rats. Medial cross sec-
tional area, medial thickness, and media to lumen ratio
were significantly increased (W = 103, P = 0.02,
W = 105, P = 0.02, and W = 115, P = 0.003
respectively) while lumen diameter did not change
(W = 77, P = 0.5). Associated with the increased medial
thickness was an increase in the number of proliferating
cells in I3C aortas (total cell counts: W = 59.5, P = 0.1
versus control, cells per mm2: W = 56, P = 0.2).
Body weight measurements were also obtained before
and throughout the treatment protocol (Fig. 7). There
was a significant main effect of treatment (F15,140 = 24.85
P < 0.0001). Post hoc analysis indicates that the weights
tend to diverge by day 14 of I3C ingestion, which per-
sisted until the end of the study.
To address any concerns that weight loss may have had
a negative impact on our cognitive measures, a food
restriction study was performed in wild type F344 rats
(n = 3 food restricted; n = 3 ad libitum). The body
weights in the restricted group were decreased to the
same amount as the I3C-treated animals beginning in the
second week of the experiment, and continued for
27 days. There was a main effect of treatment on weight
(F28,240 = 24.90, P < 0.001), with post hoc analysis indi-
cating a significant difference by day 27 (P < 0.001).
There was no main effect of treatment on blood pressure
or on cognition between groups (P > 0.05; Fig. 8).
Discussion
The experiments in this study examined the cardiovascu-
lar, renal, and neurological effects of hypertension induc-
tion in middle-aged rats. Our approach included a slow
induction of hypertension at an age in the rat that is
equivalent to the human manifestation of primary
Figure 3. Hypertension has no effect on visual cued Morris swim task performance. A visual cued version of the Morris swim task was
performed during the PRE and POST phases of the experiment (dark gray: I3C treated, n = 13; light gray: Control, n = 12). There were no
statistically significant differences detected due to I3C treatment. These results demonstrate that hypertension did not significantly impair vision
or alter swimming speed in the Cyp1a1-Ren2 animals.
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hypertension. Middle-aged induction with a slow rise in
blood pressure was our attempt to more closely model
the human disease. Inducing hypertension in this fashion
resulted in significant changes in systolic and diastolic
blood pressures (Fig. 1) as well as cardiovascular and
renal end organ damage (Figs. 4–6). We recognize that
the control diet fed animals also demonstrated a slightly
elevated blood pressure as well, and this change may be
age-related as others have found in studies utilizing rats
(Bu~nag and Ter€av€ainen 1991). Additionally, we observed
a small but statistically significant reduction in the ability
of rats to benefit from spatial learning pretraining, when
spatial memory was tested following hypertension induc-
tion (Fig. 3). Hypertension induction, however, had no
effect on visual discrimination or swim speed (Fig. 2). In
summary, modeling hypertension in this fashion pro-
duced much of the predicted peripheral, as well as the less
well understood cognitive effects of hypertension.
We noted a potential confound in our model related to
weight loss, potentially due to reduced food intake
(Fig. 7), although this was not directly investigated. Since
weight loss could indicate suboptimal nutrition and that
in turn could influence cognitive status we performed a
control experiment where food deprivation was used to
cause a longitudinal drop in body weight. In the food
deprived animals we did not note an influence on cogni-
tive performance in the Morris water maze (Fig. 8)
suggesting that the significant changes we noted in the
animals with hypertension were not related to their grad-
ual weight loss and are most likely a consequence of the
increased activation of the renin angiotensin system.
We propose that processes associated with aging should
be considered when hypertension is modeled in the
rodent. In the human condition, prehypertension and
hypertension occur in midlife. Hypertension in midlife
has been associated with a higher risk of dementia or
poor cognitive function later in life (Launer 1995; Yano
et al. 2014; Gottesman et al. 2017). The Cyp1a1-Ren2 rat
model has not previously been used to study the effects
of hypertension on cognition. Many of the approaches in
the field induce hypertension in animals that are younger
than the equivalent human patient and they also tend to
utilize very rapid induction approaches that result in a
rise in blood pressure that is estimated to be much stee-
per than is typically the case in humans. Of note, the
Cyp1a1-Ren2 rat is well suited for the study of age-related
changes and hypertension since the model is based on the
Fisher-344 rat, a rodent model developed by the National
Institute on Aging at the NIH. Because of this fact, there
are many studies that have examined aging as well as cog-
nition in this background strain that can be used as
appropriate starting points for future study. The noninva-
siveness of the model is also a positive aspect that helps
facilitate its use in the study of aging. Without the need
P = 0.01
Figure 4. I3C treatment significantly increases cardiac and renal measurements of end organ damage. End organ damage was measured in
each animal at sacrifice. I3C (n = 13) treated animals are shown here as dark gray, and control (n = 12) animals as light gray. These results
demonstrate that the I3C induction of hypertension was sufficient to increase common measures of cardiac and renal end organ damage in the
Cyp1a1-Ren2 animals. Wilcoxon ranked sum test P-values are indicated for each comparison.
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for surgical intervention there are generally fewer compli-
cations associated with the model. Additionally the use of
a xenobiotic induction approach lends itself well to align-
ing with an ideal antihypertensive therapy. That is, ani-
mals can simply be switched to normal chow, which in
turn shuts off the expression of the renin transgene, to
evaluate the impact of removing the initial hypertensive
stimulus.
The underlying mechanism responsible for the impair-
ment in the ability of rats to benefit from spatial learning
pretraining in this study remains to be determined. In
addition to hypertension and upregulation of the renin
angiotensin system, systemic inflammation secondary to
target organ damage have each been associated with
impaired cognitive function (Guo et al. 2017; Yamanaka
et al. 2017; Ahmed et al. 2018; Dhanda et al. 2018). Cen-
tral inflammation is likely not responsible for the effects
seen in the present manuscript as others have shown that
greater than 4 months of I3C treatment in Cyp1a1-Ren2
rats was required to induce an increase in microglia (Pan-
nozzo et al. 2013). Given the modest effects that we
observed after only 32 days of I3C treatment, it would be
interesting to see the effects of long-term induction on
cognition using this model. Long-term induction of
hypertension in aged Cyp1a1-Ren2 rats with a high-fat
diet have been shown to have microstructural alterations
but no white matter lesions (Holland et al. 2015). These
modest changes, as well as the modest changes seen in
our work, are an indication that this model could be ben-
eficial in observing the mechanisms at play in the human
condition.
Limitations in our study include, first, the weight loss
associated with the xenobiotic diet. We controlled for the
weight loss but could not control for other unrecognized
effects that the diet may have had on the animal. We did,
however, characterize swimming speeds and vision in the
Morris swim task, and both of those measurements were
equivalent between treated and untreated animals. We
also treated nontransgenic F344 rats with I3C and control
diet to examine the potential effect of this xenobiotic
compound on body weight, blood pressure, and spatial
behavior. There was no impact of I3C on any of these
variables, suggesting that the xenobiotic diet only had an
effect on the transgenic animals. Secondly, blood pressure
measurements were conducted using indirect approaches.
Our use of indirect blood pressure measurements instead
Figure 5. Hypertension results in significantly elevated cardiac and renal fibrosis. Representative images from heart and kidney tissue using
Masson’s trichrome stain to indicate collagen fibrosis. Images that scored nearest the group means are illustrated here.
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of surgical intervention on the middle-aged animals likely
resulted in a larger standard deviation for the blood pres-
sure measurements. Regardless of this, the induced
animals demonstrated a significant rise in both systolic
and diastolic pressures compared to the untreated rats.
Lastly, only spatial reference memory was assessed in the
Figure 6. Hypertension induces end organ damage in the aorta. I3C (n = 13) treatment induced aortic hypertrophy as evidenced by increases
in medial cross-sectional area (CSA), medial thickness, and the media to lumen ratio. Increased cellular proliferation was evaluated based on the
number of cells positively labeled with anti-proliferating cell nuclear antigen (PCNA). Wilcoxon ranked sum test P-values are indicated for each
comparison.
Figure 7. I3C treatment is associated with significant body weight loss after 2 weeks. The I3C (n = 13) treated animals have significant drops
in body weight by the end of the experimental period. Post hoc analysis suggests that weight tends to diverge by day 14 (**P < 0.01,
***P < 0.001, N.S. = not significant).
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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animals. Future work should explore a more detailed bat-
tery of behavior tasks to examine what cognitive domains
are most strongly influenced by hypertension. A battery
of assessments is used to determine cognitive function
when studying the effects of hypertension on cognition in
humans (Iadecola et al. 2016), and it would be beneficial
to include a battery that closely mimics the assessments
in animal work as well.
In summary, we utilized an inducible model of hyper-
tension and attempted to closely mimic both the age-at-
onset and slow blood pressure rise associated with human
primary hypertension. Induction of hypertension resulted
in predicted changes to cardiac, renal, and vascular end
organs as well as to spatial reference memory perfor-
mance. These findings suggest that the Cyp1a1-Ren2 rat
model is amenable to the study of hypertension in middle
age and that the phenotype mimics both the peripheral
and central alterations associated with elevated blood
pressure that is noted in the human.
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